Partnership aims to integrate AI to assist ambulance-based stroke diagnosis
In an effort to help paramedics and EMTs more quickly and accurately assess stroke patients in prehospital environments, MedyMatch Technology and Samsung NeuroLogica have teamed up to integrate artificial intelligence (AI) clinical decision support applications with Samsung NeuroLogica's medical imaging hardware.
By integrating MedyMatch's artificial intelligence technology into ambulance-based mobile stroke units equipped with Samsung NeuroLogica's CereTom computed tomography scanner, the companies say first responders can more easily use CT scans to determine whether a patient is suffering from a blood clot or hemorrhage.
"Imaging technological development has been historically focused on providing clinicians the best possible image, optimizing spatial and temporal resolution, coverage and dose,” Gene Saragnese, Chairman & CEO of MedyMatch, explained in an announcement. “However, MedyMatch's artificial intelligence applications will leap this paradigm forward, enabling Imagers such as CT to provide clinical answers and not just images, (thus) creating the truly intelligent imaging machine to assist physicians every day."
With nearly 800,000 Americans suffering a stroke each year, most of them caused by clot obstruction in the brain, faster patient assessment can enable caregivers to follow the most appropriate treatment path, even while still in transit to the hospital.
While ischemic strokes, which occur when blood flow to the brain is obstructed by a clot in a blood vessel, can be treated with a tissue plasminogen activator, or tPA, it must be administered within three hours. Currently, it can take an hour after a stroke patient arrives in the ED to receive treatment because of the time needed to determine which kind of stroke the patient is having.